FEATURES OF FUNCTIONAL ACTIVITY IN PATIENTS WITH SARCOPENIC OBESITY AND VISUAL IMPAIRMENT
Abstract
Introduction. Age-associated glaucoma and diabetic retinopathy in combination with sarcopenic obesity, formed mainly against the background of physical inactivity due to vision deficiency, potentially contribute to a decrease in patients’ activity in daily life, but the latter has not been studied practically by special tests taking into account visual impairment. The aim. Study the peculiarities of the influence of diabetic retinopathy and primary glaucoma on the daily activities of patients with sarcopenic obesity. Materials and methods. 125 patients aged 60–74 years with sacropenic obesity and diabetic retinopathy, 138 patients of the same age with sacropenic obesity and primary stage IIa glaucoma were examined in clinical conditions. The diagnosis of glaucoma and diabetic retinopathy was performed based on the results of a comprehensive clinical and hardware examination of patients and in accordance with the criteria of the National Guidelines. Sarcopenia was detected using the European working group on sarcopenia in older people scale, and obesity was measured by a body mass index ≥30 kg/m2. The assessment of activities in everyday life was carried out according to a specific test developed by us. Results and discussion. A more significant effect of diabetic retinopathy combined with sacropenic obesity, causing complete dependence on others (12,18 points) in daily life activities, was found than the effect of glaucoma combined with sacropenic obesity, causing moderate dependence — 10,18 points (p <0,01). Patients of the compared groups also have statistically significant differences in all types of activities in everyday life, including leading ones — threading a needle and cutting
nails. In particular, restrictions on threading into a needle in patients with diabetic retinopathy and sacropenic obesity have 1,84±0,03 points, which is significantly higher than in patients with
glaucoma and sacropenic obesity (p <0,01). A similar pattern has been established for nail clipping, the limits for which are 1,75±0,03 points and 1,43±0,04 points, respectively. Conclusions. The
revealed features of the effect of glaucoma and diabetic retinopathy, combined with sacropenic obesity, should be used by ophthalmologists when forming recommendations on the behavior of
patients in everyday life.
References
Астахов Ю.С., Нероев В.В., Шестакова М.В. и др. Клинические рекомендации. Сахарный диабет: ретинопатия диабетическая, макулярный отек диабетический. М.: Общероссийская общественная организация «Ассоциация врачей-офтальмологов»; 2020.
Копылов А.Е., Османов Р.Э. Тест базовой функциональной активности пациентов с нарушением зрения. Проблемы и успехи современной геронтологии и гериатрии. 2019; 1: 26–8.
Лев И.В., Агарков Н.М., Стародубцева Л.В. Гериатрическая тактика ведения пациентов с диабетической ретинопатией. Научные результаты биомедицинских исследований. 2023; 9(1): 129–41. DOI: 10.18413/2658-6533-2023-9-1-0-9.
Нестеров А.П. Глаукома изд. 2-е. М.: Медицинское информационное агентство; 2014.
Burton M.J., Ramke J., Marques A.P. et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Glob Health. 2021; 9(4): е489–551. DOI: 10.1016/s2214-109x(20)30488-5.
Chiu C.J., Li M.L., Chou C.Y. Trends and biopsychosocial correlates of physical disabilities among older men and women in Taiwan: examination based on ADL, IADL, mobility, and frailty. BMC Geriatr. 2022; 22(1): 148. DOI: 10.1186/s12877-022-02838-6.
Fukuda T., Bouchi R., Takeuchi T. et al. Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: a cross-sectional study. BMJ Open Diabetes Res Care. 2017; 5(1): е000404. DOI: 10.1136/bmjdrc-2017-000404.
Hochberg C., Maul E., Chan E.S. et al. Association of vision loss in glaucoma and age-related macular degeneration with IADL disability. Invest Ophthalmol Vis Sci. 2012; 53(6): 3201–6. DOI: 10.1167/iovs.12-9469.
Kim B.R., Yoo T.K., Kim H.K. et al. Oculomics for sarcopenia prediction: a machine learning approach toward predictive, preventive, and personalized medicine. EPMA J. 2022; 13(3): 367–82. DOI: 10.1007/s13167-022-00292-3.
Mlinac M.E., Feng M.C. Assessment of Activities of Daily Living, Self-Care, and Independence. Archives of Clinical Neuropsychology. 2016; 31(6): 506–16. DOI: 10.1093/arclin/acw049.
Ting D.S., Cheung C.Y., Nguyen Q. et al. Deep learning in estimating prevalence and systemic risk factors for diabetic retinopathy: a multi-ethnic study. NPJ Digit Media. 2019; 2: 24. DOI: 10.1038/s41746-019-0097-x.
Viarsagh S.B., Zhang M.E., Shariflou S. et al. Cognitive Performance on the Montreal Cognitive Assessment Test and Retinal Structural and Functional Measures in Glaucoma. J Clin Med. 2022; 11(17): 5097. DOI: 10.3390/jcm11175097.
Wei S., Nguyen T.T., Zhang Y. et al. Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management. Front Endocrinol (Lausanne). 2023; 14: 1185221. DOI: 10.3389/fendo.2023.1185221.
Zhao X., Liu W., Lu B. et al. Visual impairment and depression in China: a 7-year follow-up study from national longitudinal surveys. BMJ Open. 2022; 12(4): е055563. DOI: 10.1136/bmjopen-2021-055563.
